Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

BioNTech SE Initial Public Offering on Nasdaq

Davis Polk advised the underwriters in connection with the $150 million initial public offering of 10,000,000 American Depositary Shares of BioNTech SE. In addition, the underwriters have…

Aprea Therapeutics, Inc. Initial Public Offering

Davis Polk advised the underwriters in connection with the $97.75 million initial public offering of 6,516,667 shares of common stock of Aprea Therapeutics, Inc., which includes 850,000…

PerkinElmer, Inc. $850 Million Notes Offering

Davis Polk advised the joint bookrunners in connection with an offering by PerkinElmer, Inc. of $850 million aggregate principal amount of its 3.300% notes due 2029. Headquartered in…
Back to top